A nurse is caring for a client who is receiving nitroglycerine IV and is switching to the oral form of the medication. The nurse should identify that the oral dose will be higher than the IV dose for which of the following reasons?

A. The oral route has lower bioavailability compared to IV administration since it has to be metabolized by the liver, necessitating a higher dose to achieve the desired effect: Nitroglycerin undergoes extensive first-pass metabolism in the liver when taken orally, reducing the amount that reaches systemic circulation. As a result, a higher oral dose is required to achieve the same therapeutic effect as an IV dose, which bypasses hepatic metabolism. B. The IV route has decreased absorption compared to the oral route, necessitating a higher oral dose for equivalent effect: IV administration delivers the medication directly into the bloodstream, providing 100% bioavailability. Absorption is not decreased with IV use; oral absorption is actually less efficient due to first-pass metabolism. C. The oral route provides more rapid onset of action compared to IV administration, requiring a higher dose for sustained effect: IV nitroglycerin acts almost immediately, whereas oral nitroglycerin has a slower onset due to absorption and first-pass metabolism. Rapid onset is not the reason for higher oral dosing; it is the lower systemic availability. D. The oral route bypasses hepatic metabolism, leading to faster clearance and necessitating a higher dose for sustained effect: Oral medications do not bypass hepatic metabolism; they undergo first-pass metabolism in the liver, which reduces bioavailability. This is why the oral dose must be higher, not due to faster clearance.